Isabel Kalofonos

Isabel Kalofonos

Corporate Officer/Principal chez CRINETICS PHARMACEUTICALS, INC.

Fortune : 1 M $ au 31/05/2026

55 ans
Health Technology
Consumer Services

Profil

Isabel Kalofonos currently works at Crinetics Pharmaceuticals, Inc., as Chief Commercial Officer from 2024.
Ms. Kalofonos also formerly worked at Fulcrum Therapeutics, Inc., as Chief Commercial Officer in 2024, ImmunoGen, Inc., as Chief Commercial Officer & Senior Vice President from 2023 to 2024, and Galderma Holding SA, as Senior VP & Head-Prescription Business from 2020 to 2023.
Ms. Kalofonos received her Masters Business Admin degree from Babson College and undergraduate degree from Pontificia Universidad Javeriana.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
23/02/2026 34 834 ( 0,03 % ) 1 M $ 31/05/2026

Postes actifs de Isabel Kalofonos

SociétésPosteDébut
CRINETICS PHARMACEUTICALS, INC. Corporate Officer/Principal 16/12/2024

Anciens postes connus de Isabel Kalofonos

SociétésPosteFin
FULCRUM THERAPEUTICS, INC. Corporate Officer/Principal 30/09/2024
IMMUNOGEN, INC. Corporate Officer/Principal 01/08/2024
Corporate Officer/Principal 01/03/2023
Voir l'expérience en détail de Isabel Kalofonos

Formation de Isabel Kalofonos

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

12

Relations au 1er degré

6

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées6

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Isabel Kalofonos
🔇